TriSalus Life Sciences, Inc. TLSI Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s operating income?
- TriSalus Life Sciences, Inc. (TLSI) reported operating income of -$8.41M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s operating income changed year-over-year?
- TriSalus Life Sciences, Inc.'s operating income decreased by 14.8% year-over-year, from -$7.33M to -$8.41M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s operating income?
- Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s operating income has grown at a 72.5% compound annual growth rate (CAGR), from -$3.04M to -$26.95M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.